clinical trial · NCT07152236
Clinical Study on the Safety and Efficacy of B7H3 CAR T Cells in Patients With B7H3 Positive Solid Tumors
Guangzhou Bio-gene Technology Co., Ltd·N/A·recruiting·n = 20
Solid TumorsCAR-T
brief summary
This single-arm, single-center investigator-initiated trial (IIT) evaluates the safety, efficacy, and pharmacodynamic (PD)/pharmacokinetic (PK) profiles of CAR-T cells in patients with advanced solid tumors. Eligible subjects are followed until 12 months after infusion or until meeting treatment withdrawal criteria, whichever occurs first.
started
Aug 31, 2025
primary completion
Aug 31, 2028
completion
Aug 31, 2028
last updated
Sep 3, 2025
official title
A Clinical Study Evaluating the Safety and Efficacy of B7H3 CAR-T Cell Therapy in Patients With B7H3-Positive Solid Tumors
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol